RAPID-RF: Remote Active Monitoring in Patients With Heart Failure
This study has been completed.
Sponsor:
Boston Scientific Corporation
Information provided by:
Boston Scientific Corporation
ClinicalTrials.gov Identifier:
NCT00334451
First received: June 5, 2006
Last updated: September 8, 2008
Last verified: September 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The RAPID-RF Registry aims to characterize LATITUDE® Patient Management's alert feature: LATITUDE Active Monitoring™ by evaluating type and frequency of alert notifications and alert-related medical interventions. This registry will also assess clinical outcomes including quality of life and New York Heart Association Class changes over time, mortality, hospitalizations and heart failure-related event rates.
Study Type: | Observational |
Study Design: | Observational Model: Cohort Time Perspective: Prospective |
Official Title: | Remote Active Monitoring in Patients With Heart Failure |
Resource links provided by NLM:
Further study details as provided by Boston Scientific Corporation:
Eligibility
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Study Population
Primary care clinics, heart failure clinics, hospitals
Criteria
Inclusion Criteria:
- Patients who meet current indications for a Guidant RF-enabled CRT-D device (e.g. CONTAK RENEWAL 3 RF family of CRT-D devices) which is compatible with the LATITUDE Communicator. Indications include: NYHA Class III, IV; EF of ≤ 35%; QRS duration of ≥ 120 ms; and optimized pharmacologic therapy
- Patients who have an analog telephone line compatible with the LATITUDE Communicator. The LATITUDE Communicator must be placed within 8 feet of where they sleep for successful remote interrogations to occur.
- Patients who receive the study components including the LATITUDE Communicator, weight scale, and blood pressure monitor
- Patients who are willing and capable of providing informed consent prior to implant and willing to participate in the RAPID-RF Registry
- Patients who remain in the clinical care of a RAPID-RF investigator at approved centers
Exclusion Criteria:
- Patients who are expected to receive a heart transplant during the course of the study
- Patients who have received or who will receive a tricuspid valve prosthesis during the course of the study
- Patients who have previously received an implantable cardiac resynchronization device (e.g., biventricular pacemaker or biventricular ICD)
- Patients whose life expectancy is less than 12 months
- Patients who are currently enrolled in another observational registry or investigational study that could directly impact the treatment or outcome of the RAPID-RF Registry. Contact Guidant's Clinical Application Research Study (CARS) department to determine eligibility.
- Patients who are younger than 18 years of age
- Patients who are pregnant or plan to become pregnant during the study
- Patients who are unable or refuse to comply with the protocol requirements
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00334451
Locations
United States, New York | |
Long Island Jewish Medical Center | |
New Hyde Park, New York, United States, 11040 |
Sponsors and Collaborators
Boston Scientific Corporation
Investigators
Principal Investigator: | Leslie A Saxon, MD | University of Southern California |
Principal Investigator: | John P Boehmer, MD | Hershey Medical Center, Hershey, PA |
More Information
No publications provided by Boston Scientific Corporation
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Keywords provided by Boston Scientific Corporation:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on October 16, 2012
No publications provided by Boston Scientific Corporation
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Steven McQuillan, Boston Scientific |
ClinicalTrials.gov Identifier: | NCT00334451 History of Changes |
Other Study ID Numbers: | CR-CA-030206-H, RAPID RF |
Study First Received: | June 5, 2006 |
Last Updated: | September 8, 2008 |
Health Authority: | United States: Institutional Review Board |
Keywords provided by Boston Scientific Corporation:
Heart Failure Remote Monitoring Implantable Device |
Additional relevant MeSH terms:
Heart Failure Heart Diseases Cardiovascular Diseases |
ClinicalTrials.gov processed this record on October 16, 2012